Clinical-grade autonomous cytopathology through whole-slide edge tomography
Cytopathology, often abbreviated as cytology, has a central role in the early detection of cancer, such as cervical, lung and bladder cancers, owing to its speed, simplicity and minimally invasive nature<sup>1-9</sup>. However, its effectiveness is limited by variability in diagnostic accuracy stemming from subjective visual interpretation<sup>10-21</sup>. Although many artificial intelligence (AI)-powered systems have been proposed to improve consistency<sup>22-26</sup>, none have achieved fully autonomous, clinical-grade performance. Existing approaches serve as assistive tools and still rely on human oversight for interpretation and decision-making<sup>22-26</sup>. Here we present a clinical-grade autonomous cytopathology pipeline that combines high-resolution, real-time optical whole-slide tomography with edge computing to deliver end-to-end automation. The system achieves practical performance in imaging speed, quality and data volume, with localized data compression enabling streamlined storage and accelerated AI-driven analysis. In addition to supporting cell-level classification, the platform enables flow cytometry-like, population-wide morphological profiling for comprehensive interpretation of cellular distributions and patterns. A vision transformer achieved area under the receiver operating characteristic (ROC) curve (AUC) values exceeding 0.99 at the single-cell level for detecting low-grade squamous intraepithelial lesions (LSILs), high-grade squamous intraepithelial lesions (HSILs) and adenocarcinoma. In a multicentre evaluation of 1,124 cervical liquid-based cytology samples across four centres, the AI model achieved slide-level AUC values of 0.86-0.91 for LSIL<sup>+</sup> and 0.89-0.97 for HSIL<sup>+</sup>, with LSIL counts correlating strongly with human papillomavirus positivity and HSIL counts scaling with diagnostic severity. The system enables autonomous triage cytology, offering a foundation for routine, scalable and objective diagnostics.
Authors
- Tianben Ding (ORCID: https://orcid.org/0000-0003-0710-2344)
- Miyaka Umemori
- Yukihito Mase
- Hiroyuki Ohsaki
- Nao Nitta (ORCID: https://orcid.org/0000-0002-9093-9016)
- Yukari Himeji
- Koichi Ikebata
- Takahiko Ito (ORCID: https://orcid.org/0000-0001-5257-897X)
- Tomohiro Chiba (ORCID: https://orcid.org/0000-0003-4374-9997)
- Peter Koh
- Goda Keisuke
- Hideji Nakamura (ORCID: https://orcid.org/0000-0002-3512-3209)
- Takeaki Sugimura (ORCID: https://orcid.org/0000-0002-3744-2799)
- Joseph Zonghi
- Robert Y. Osamura
- Meisam Hasani
- Akane Hashizume
- Miki Kanematsu
- Shuhei Ishii
- Nagisa Hosoya
- Hitoshi Abe
- Yusuke Kobayashi
- Aditya Jain
- Fernando C. Schmitt
- Raihan Ull Islam
- Yingdong Luo
- Hiroyuki Kanao
- Ayumi Shikama
- Noureldin M. Z. Ali
- Yuko Sugiyama
- Yoshihiko Murata
- Daisuke Matsubara
Institutions
- University of Tsukuba (JP)
- Tokyo University of Science (JP)
- University of California, Los Angeles (US)
- Universidade do Porto (PT)
- Tohoku University (JP)
- Kaetsu University (JP)
- CYBO (Japan) (JP)
- The Cancer Institute Hospital (JP)
- Juntendo University Urayasu Hospital (JP)
- Nippon Koei (Japan) (JP)
- The University of Tokyo (JP)
- Wuhan Institute of Technology (CN)
Publication Details
- Journal
- Nature
- Published
- 2026-02-18
- DOI
- https://doi.org/10.1038/s41586-025-10094-y
- Citations
- 2
- Primary Topic
- AI in cancer detection
- Type
- article
- Field-Weighted Citation Impact
- 104.19